STRUCTURAL DAMAGE PROGRESSION IN PATIENTS TREATED WITH METHOTREXATE, BARICITINIB MONOTHERAPY OR BARICITINIB plus METHOTREXATE BASED ON THEIR LEVEL OF CLINICAL RESPONSE IN THE PHASE 3 RA-BEGIN STUDY
Author(s):
Heijde, D. van der; Durez, P.; Schett, G.; Naredo, E.; Ostergaard, M.; Meszaros, G.; Bello, N.; Torre, I. de la; Lopez-Romero, P.; Schlichting, D.; Nantz, E.; Fleischmann, R.
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-06-30
Language
English
Is part of
Annals of the Rheumatic Diseases (2017), Vol. 76, p. 233-233
